Tag Archives: biotechnology

NCDEU Meeting continued…

Posted on July 1, 2011 by Lawrence Friedhoff, MD, PhD, FACP

Some interesting conversations at the NCDEU Meeting. One of my more interesting conversations was with a professor from a prominent business school.  When I challenged the high number for the cost of a new drug approval he quoted, he told … Continue reading →

Posted in Biotech, Cost of Drug Development, FDA, Investor, New drug development, Pharmaceutical Companies, Uncategorized | Tagged , , , , | Leave a comment